Taken together, these observations suggest novel mechanisms of URB597 and insights into cognitive impairment during ischemic cerebrovascular diseases, and identify CB2 as a potential target for therapy of ischemic cerebrovascular diseases. The gene discussed is CNR2; the disease is Cognitive impairment.